{
    "nctId": "NCT00890903",
    "briefTitle": "Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)",
    "officialTitle": "Usage of Vinorelbin ORAL (Navelbine\u00ae ORAL) in the Treatment of Advanced Non-small Cell Lung Cancer(NSCLC)and Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Non Small Cell Lung Carcinoma, Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 62,
    "primaryOutcomeMeasure": "Progression-free-survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 18 years old\n* Male and female patients\n* Advanced NSCLC (Stage III or IV) or Antracycline-resistant MBC\n* Therapy with Navelbine capsules in any palliative treatment line\n* Signed patient informed consent\n\nExclusion Criteria:\n\n* Pregnancy and nursing\n* All other exclusion criteria listed in SPC (summary of product characteristics)\n* lack of signed Patient informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}